Join
Live feed
·
INSIDERFilingvia Quantisnow
Gain Therapeutics Inc. logo

SEC Form 4: Richman Eric I bought $38,716 worth of shares (4,922 units at $7.87), increasing direct ownership by 2% to 216,820 units (Amendment)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GANX (Gain Therapeutics Inc.) and more on Quantisnow.